| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 7,317,852 | 3,537,047 |
| Net change in cash | -3,656,901 | -2,731,514 |
| Cash and cash equivalents at beginning of period | 5,533,527 | - |
| Cash and cash equivalents at end of period | 1,876,626 | - |
OS Therapies Inc (OSTX)
OS Therapies Inc (OSTX)